PROK ProKidney Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: PROK

Price (delayed)

$1.65

Market cap

$498.83M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.55

Enterprise value

$427.49M

?
Relative Growth: Rel. Growth: 22
Relative Strength: Rel. Strength: 19
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 25
Highlights
ProKidney's debt has decreased by 20% YoY and by 7% from the previous quarter
ProKidney's equity has increased by 14% from the previous quarter and by 12% YoY
ProKidney's gross profit has surged by 55% YoY but it has decreased by 8% QoQ
ProKidney's revenue has soared by 55% YoY but it has decreased by 8% from the previous quarter
PROK's quick ratio is down by 23% YoY and by 8% QoQ
The net income has declined by 16% since the previous quarter and by 16% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: https://www.prokidney.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of PROK

PROK stock price

How has the ProKidney stock price performed over time
Intraday
-9.84%
1 week
-10.81%
1 month
2.48%
1 year
-39.78%
YTD
-26.34%
QTD
-19.12%

Financial performance

How have ProKidney's revenue and profit performed over time
Revenue
$818,000
Gross profit
$818,000
Operating income
-$177.22M
Net income
-$84.16M
Gross margin
100%
Net margin
-10,288.4%
ProKidney's gross profit has surged by 55% YoY but it has decreased by 8% QoQ
ProKidney's revenue has soared by 55% YoY but it has decreased by 8% from the previous quarter
ProKidney's operating margin has increased by 37% YoY but it has decreased by 14% QoQ
ProKidney's net margin has decreased by 27% from the previous quarter but it has increased by 25% YoY

Price vs fundamentals

How does PROK's price correlate with its fundamentals

Growth

What is ProKidney's growth rate over time

Valuation

What is ProKidney stock price valuation
P/E
N/A
P/B
N/A
P/S
376.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
522.6
The EPS has declined by 3.8% since the previous quarter but it has increased by 3.5% year-on-year
ProKidney's equity has increased by 14% from the previous quarter and by 12% YoY
ProKidney's revenue has soared by 55% YoY but it has decreased by 8% from the previous quarter
PROK's P/S is 9% above its last 4 quarters average of 381.5

Efficiency

How efficient is ProKidney business performance
The return on invested capital has dropped by 89% year-on-year and by 35% since the previous quarter
The return on assets has dropped by 60% year-on-year and by 28% since the previous quarter
The return on sales has declined by 28% since the previous quarter but it has increased by 23% year-on-year

Dividends

What is PROK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PROK.

Financial health

How did ProKidney financials performed over time
ProKidney's total assets has decreased by 33% YoY and by 15% QoQ
The current ratio has declined by 27% year-on-year and by 8% since the previous quarter
ProKidney's debt is 100% more than its equity
ProKidney's debt has decreased by 20% YoY and by 7% from the previous quarter
ProKidney's equity has increased by 14% from the previous quarter and by 12% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.